Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![raghavwadhwa Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::100281231.png) Raghav Wadhwa [@raghavwadhwa](/creator/twitter/raghavwadhwa) on x 97.1K followers
Created: 2025-07-17 09:09:31 UTC

🔷Competitive Landscape: Key Players and Pipeline Developments:

🔸Market Leaders and Innovators 
🔹Novo Nordisk dominates the current Indian GLP-1 market, primarily through oral semaglutide (Rybelsus), which holds approximately XX% market share as of recent reports.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945772844417249655/c:line.svg)

**Related Topics**
[$novcde](/topic/$novcde)

[Post Link](https://x.com/raghavwadhwa/status/1945772844417249655)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

raghavwadhwa Avatar Raghav Wadhwa @raghavwadhwa on x 97.1K followers Created: 2025-07-17 09:09:31 UTC

🔷Competitive Landscape: Key Players and Pipeline Developments:

🔸Market Leaders and Innovators 🔹Novo Nordisk dominates the current Indian GLP-1 market, primarily through oral semaglutide (Rybelsus), which holds approximately XX% market share as of recent reports.

XXXXX engagements

Engagements Line Chart

Related Topics $novcde

Post Link

post/tweet::1945772844417249655
/post/tweet::1945772844417249655